The first stop for professional medicines advice

Cancers

12 results

RelevanceNewest firstOldest firstTitle
Applied filters

Trastuzumab: informing intrathecal risk assessment

11 August 2022Trastuzumab products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Topotecan: informing intrathecal risk assessment

11 August 2022Topotecan products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Thiotepa: informing intrathecal risk assessment

11 August 2022Thiotepa products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Switching between morphine and other opioids in palliative care

14 September 2021Switching between morphine and alternative opioids requires care and thoughtful application of a stepped process

Rituximab: informing intrathecal risk assessment

11 August 2022Rituximab products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Methotrexate: informing intrathecal risk assessment

11 August 2022Methotrexate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Hydrocortisone: informing intrathecal risk assessment

11 August 2022Hydrocortisone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Hydrocortisone acetate: informing intrathecal risk assessment

11 August 2022Hydrocortisone acetate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

How should adults with cancer be managed by general dental practitioners if they need dental treatment?

23 March 2020This Medicines Q&A provides advice on what to consider when providing dental treatment, and information about the main adverse effects of cancer therapies that could…

Etoposide: informing intrathecal risk assessment

11 August 2022Etoposide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration